Aptose Biosciences, Inc. (NASDAQ:APTO) will hold its 3Q20 earnings conference call with the financial community on 10th November 2020 at 5:00 PM Eastern Time.
The conference call will be webcast live on Internet at www.aptose.com
Earnings Expectation
Aptose Biosciences, Inc. a clinical-stage biotechnology company, is expected to report third quarter earnings results, after market close, on Tuesday 10th November 2020.
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Its clinical programs is APTO-253, which is a Phase Ib clinical trial for the treatment of patients with relapsed/refractory blood cancers, including acute myeloid leukemia and high-risk myelodysplastic syndrome. It has an agreement with CrystalGenomics, Inc.
